Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York.
Praxis Precision Medicines, Cambridge, Massachusetts.
Ann Clin Transl Neurol. 2019 Sep;6(9):1718-1727. doi: 10.1002/acn3.50865. Epub 2019 Aug 15.
Experimental therapies under development for Friedreich's Ataxia (FRDA) require validated biomarkers. In-vivo reflectance confocal microscopy (RCM) of skin is a noninvasive way to quantify Meissner's corpuscle (MC) density and has emerged as a sensitive measure of sensory polyneuropathies. We conducted a prospective, cross-sectional study evaluating RCM of MCs and conventional peripheral nerve measures as candidate peripheral nerve markers in FRDA.
Sixteen individuals with FRDA and 16 age- and gender-matched controls underwent RCM of MC density and morphology, skin biopsies for epidermal nerve fiber density (ENFD), nerve conduction studies (NCS), and quantitative sensory testing (QST) including touch, vibration, and cooling thresholds.
MC densities were measurable in all participants with FRDA, and were lower at digit V (hand), thenar eminence, and arch (foot) compared to controls. By contrast, sensory NCS showed floor effects and were obtainable in only 13% of FRDA participants. QST thresholds for touch, vibration, and cooling were higher at the hand and foot in FRDA than controls. Reductions in ENFDs were present in more severely affected individuals with FRDA (Friedreich's Ataxia Rating Scale (FARS) >60) compared to matched controls, although skin biopsies were not well tolerated in children. MC densities, ENFDs, and touch and vibration thresholds were associated with clinical disease severity (FARS and modified FARS) and duration since symptom onset.
MC density, ENFD, and QST thresholds provide structural and physiologic markers of sensory involvement in FRDA. Longitudinal evaluation is needed to determine whether these measures can identify changes associated with disease progression or treatment.
正在开发的弗里德里希共济失调(FRDA)实验疗法需要经过验证的生物标志物。皮肤的体内共聚焦反射显微镜(RCM)是量化梅斯纳小体(MC)密度的一种非侵入性方法,已成为一种敏感的感觉性多发性神经病测量方法。我们进行了一项前瞻性、横断面研究,评估了 MC 的 RCM 和常规周围神经测量作为 FRDA 中周围神经标志物的候选方法。
16 名 FRDA 患者和 16 名年龄和性别匹配的对照者接受了 MC 密度和形态的 RCM、表皮神经纤维密度(ENFD)皮肤活检、神经传导研究(NCS)和定量感觉测试(QST),包括触觉、振动和冷却阈值。
所有 FRDA 患者的 MC 密度均可测量,且与对照组相比,在第 V 指(手)、大鱼际和足弓处较低。相比之下,感觉 NCS 存在下限效应,仅 13%的 FRDA 患者可获得。FRDA 患者的手和脚的触、振动和冷却阈值均高于对照组。与匹配的对照组相比,ENFD 减少在 FRDA 中受影响更严重的患者中更为明显(Friedreich's Ataxia Rating Scale(FARS)>60),尽管皮肤活检在儿童中不能很好耐受。MC 密度、ENFD 和触觉及振动阈值与临床疾病严重程度(FARS 和改良 FARS)和症状出现后的时间有关。
MC 密度、ENFD 和 QST 阈值提供了 FRDA 感觉受累的结构和生理标志物。需要进行纵向评估,以确定这些措施是否可以识别与疾病进展或治疗相关的变化。